Method for storing dNTP

CN119095484APending Publication Date: 2024-12-06MGI TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280095418.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-06-15
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In the existing technology, the reversible blocking group of dNTP is not stable enough during storage and sequencing, causing the sequencing reaction to advance and affecting the quality and accuracy of sequencing.

Method used

Use preservation reagents including dimethyl sulfoxide, sulfolane, tetrahydrofuran, dimethylformamide, dimethylacetamide, N,N-dimethylformamide and N-methylformamide to dissolve dNTPs and improve their Stability enables long-term storage at room temperature.

Benefits of technology

It effectively avoids the hydrolysis of the reversible blocking group, extends the shelf life of dNTP, ensures the accuracy and efficiency of amplification and sequencing, and reduces the error rate and premature reaction phenomenon.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095484A_ABST
    Figure CN119095484A_ABST
Patent Text Reader

Abstract

The invention provides a preservation reagent of dNTP (deoxyribonucleoside triphosphate), and the preservation reagent of the dNTP comprises one or more of dimethyl sulfoxide, sulfolane, tetrahydrofuran, dimethyl formamide, dimethylacetamide, N, N-dimethyl formamide, N-methyl formamide and N-methyl pyrrolidone. According to the present invention, with the dNTP preservation reagent, the dNTP, especially the dNTP modified by the reversible blocking group, can be dissolved, and the stability of the dNTP can be improved, such that the dNTP can be stored for a long time, and the accuracy and the high efficiency of amplification and sequencing can be easily ensured.
Need to check novelty before this filing date? Find Prior Art

Description

How to store dNTPs Technical Field

[0001] The present invention relates to the biological field, and in particular to a method for preserving dNTPs. Background Art

[0002] The most widely used technique in current high-throughput sequencing is sequencing by synthesis (SBS). This requires that the 3'-hydroxyl end of dNTPs be attached to a cleavable blocking group. This cleavable blocking group must meet three conditions: 1) it must not interfere with the efficient and accurate polymerization of modified dNTPs by DNA polymerase into the 3'-hydroxyl end of the sequencing chain; 2) it must be sufficiently stable: during storage and sequencing reactions, the cleavable blocking group must remain stably attached to the 3'-hydroxyl end of the dNTPs and not break; and 3) it must be easily cleaved: after a single sequencing cycle, the cleavable blocking group can be efficiently cleaved off, restoring the 3'-hydroxyl structure of the sequencing chain. If the cleavable blocking group of a dNTP is not stable enough, the blocking group can detach from the dNTP, restoring the 3'-hydroxyl group, causing the sequencing reaction to proceed prematurely (the cleavable blocking group is removed, causing the polymerization reaction to not stop when it should, resulting in the polymerization of two or more modified or unmodified dNTPs in a single cycle). This is reflected in the sequencing data as decreased sequencing quality and increased error rates.

[0003] Ester bonds, as groups that can be broken or removed to form hydroxyl groups, can be used as reversible blocking groups in sequencing. Their application has both advantages and disadvantages: the advantage is that esters are very easy to be removed or broken in aqueous solutions, especially alkaline aqueous solutions, and the speed is very fast, which is beneficial to increasing sequencing speed; the disadvantage is that they are not stable enough in aqueous solutions, which is not conducive to long-term storage.

[0004] Therefore, the preservation of dNTPs modified with reversible blocking groups remains to be studied.

[0005] Summary of the Invention

[0006] The present invention aims to, at least to some extent, address at least one of the technical problems existing in the prior art. To this end, the present invention provides a dNTP preservation reagent, the use of the reagent for preserving dNTPs, and a method for preserving dNTPs. The dNTP preservation reagent of the present invention can dissolve dNTPs (especially dNTPs modified with reversible blocking groups) and improve the stability of dNTPs, enabling long-term storage of dNTPs, thereby ensuring the accuracy and efficiency of amplification and sequencing.

[0007] In one aspect, the present invention provides a dNTP preservation reagent. According to an embodiment of the present invention, the reagent includes one or more of dimethyl sulfoxide, sulfolane, tetrahydrofuran, dimethylformamide, dimethylacetamide, N,N-dimethylformamide, N-methylformamide, and N-methylpyrrolidone. The inventors have discovered that the use of this reagent can dissolve dNTPs (especially dNTPs modified with reversible blocking groups) and improve the stability of dNTPs, allowing for long-term storage of dNTPs, which is beneficial for ensuring the accuracy and efficiency of amplification and sequencing.

[0008] According to an embodiment of the present invention, the above-mentioned dNTP preservation reagent may also have the following additional technical features:

[0009] According to an embodiment of the present invention, the reagent is used to improve the storage stability of dNTP.

[0010] According to an embodiment of the present invention, the dNTP is modified with a reversible blocking group. Storing the dNTP modified with a reversible blocking group in the above reagent can effectively avoid the hydrolysis of the reversible blocking group and improve its stability.

[0011] According to an embodiment of the present invention, the reversible blocking group is selected from at least one of the following: an ester bond, an amide, an imide, an ether bond, an anhydride, an acyl chloride, a carbonate, and a carbamate. dNTPs having such reversible blocking groups exhibit good stability in the reagent and are less susceptible to hydrolysis, thereby extending their shelf life and allowing storage at room temperature for at least one year.

[0012] In another aspect, the present invention provides a reagent for preserving dNTPs. According to an embodiment of the present invention, the reagent is selected from the dNTP preservation reagent described above. This reagent can dissolve dNTPs and improve their stability, enabling long-term storage, which helps ensure the accuracy and efficiency of amplification and sequencing.

[0013] In yet another aspect, the present invention provides a method for preserving dNTPs. According to an embodiment of the present invention, the method comprises: mixing the aforementioned dNTP preservation reagent with dNTPs. This reagent dissolves the dNTPs and improves their stability, enabling long-term storage, which helps ensure the accuracy and efficiency of amplification and sequencing.

[0014] According to an embodiment of the present invention, based on the total volume of the dNTP and the reagent, the reagent content is 50-99.9%. The inventors obtained the above ratio after a large number of experiments, thereby effectively improving the stability of dNTP.

[0015] Additional aspects and advantages of the present invention will be set forth in part in the description which follows and, in part, will be obvious from the description which follows, or may be learned by practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] The above and / or additional aspects and advantages of the present invention will become apparent and readily understood from the following description of the embodiments with reference to the accompanying drawings, in which:

[0017] FIG1 shows a schematic diagram of Runon (leading reaction) curve comparison analysis according to an embodiment of the present invention. DETAILED DESCRIPTION

[0018] Below, the scheme of the present invention will be explained in conjunction with embodiment.It will be understood by those skilled in the art that the following examples are only used to illustrate the present invention and should not be regarded as limiting the scope of the present invention.In the embodiment, if specific technology or conditions are not indicated, the technology or conditions described in the literature in this area or the product instructions are used.The reagents or instruments used are not indicated by the manufacturer, and are all conventional products that can be obtained by commercial purchase.

[0019] Example 1

[0020] During research on the storage stability of dNTPs, it was discovered that dissolving dNTPs in dimethyl sulfoxide, sulfolane, tetrahydrofuran, dimethylformamide, dimethylacetamide, and N-methylpyrrolidone can improve the stability of ester-modified dNTPs. The ester bonds are not easily hydrolyzed, and they can be stored at room temperature (22-28°C) for at least one year. Dimethyl sulfoxide (DMSO) has the best effect. The following details the research process and analysis of the results, using DMSO as an example.

[0021] 1. Experimental design

[0022] The dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II were dissolved in anhydrous DMSO or LTE buffer to prepare the hot mix and cold mix, respectively. Each hot mix and cold mix was divided into four aliquots (actually testing three time points, with one backup aliquot in case the experiment failed and needed to be repeated). The aliquots were sealed with sealing film and stored at room temperature (25°C). One aliquot was taken at 0 days (fresh reagent), 11 days (equivalent to a shelf life of 6 months), and 22 days (equivalent to a shelf life of 12 months) for SE50 testing. Before sequencing, 1% DMSO was added to the sequencing reagents in the LTE group, and 1% LTE was added to the sequencing reagents in the DMSO group to ensure the same composition in the sequencing reaction buffer. The Q30%, Runon (%), and AvgErrorRate (%) of the data tested at different time points were compared.

[0023] 2. Reagents, consumables, instruments and test samples

[0024] 2.1 Main reagents and consumables

[0025] Table 1 Reagents and consumables information

[0026]

[0027]

[0028] 2.2 Instruments

[0029] Table 2 Instrument information

[0030] Instrument model: Gene Cycler 6337 Sequencer MGISEQ-2000RS Qubit Instrument Qubit 4.0 Electronic Balance MS204TS

[0031] 2.3 Experimental Samples

[0032] Table 3 Sample information

[0033]

[0034] 2.4 Evaluation indicators and standards

[0035] Table 4 Evaluation criteria

[0036] Evaluation index qualified standard notes

[0037] Runon (%) the lower the better / Q30 (%) the higher the better / MappingRate (%) the higher the better / AvgErrorRate (%) the lower the better /

[0038] 3. Experimental steps

[0039] 3.1 Preparation of Hot mix (DMSO), Hot mix (LTE), Cold mix (DMSO), and Cold mix (LTE)

[0040] Table 5 Hot mix (DMSO)

[0041]

[0042] Table 6 Hot mix (LTE)

[0043]

[0044] Table 7 Cold mix(DMSO)

[0045]

[0046] Table 8 Cold mix(LTE)

[0047]

[0048] Aliquot the four mixes into four aliquots, seal with parafilm, and store at room temperature. Separately, perform sequencing on the SE50 on the same day, 10 days after preparation, and 22 days after preparation.

[0049] 3.2DNB preparation

[0050] 1) Add reagents and library according to the following system:

[0051] Table 9 DNB preparation reaction system

[0052]

[0053] The above reaction system was mixed by vortex oscillator, centrifuged for 5 seconds in a mini centrifuge, and placed in a PCR instrument for primer hybridization. The reaction conditions are shown in the table below:

[0054] Table 10 DNB preparation reaction primer hybridization conditions

[0055] Temperature Time Hot cover (105℃) On 95℃ 1min 65℃ 1min 40℃ 1min 4℃ Hold

[0056] 2) Remove the DNB polymerase mixture II (LC) and place it on ice. Centrifuge briefly for 5 seconds and place it on ice until ready to use.

[0057] 3) When the PCR instrument reaches 4°C, remove the PCR tube and centrifuge for 5 seconds. Then, add the following components to the PCR tube on ice:

[0058] Table 11 DNB preparation reaction components 2

[0059] Component addition amount (μL)DNB polymerase mixture I40DNB polymerase mixture II (LC)4

[0060] 4) Mix the reaction system by vortexing, centrifuge for 5 seconds, and immediately place in a PCR instrument. The reaction conditions are as follows:

[0061] Table 12 DNB preparation rolling circle amplification conditions

[0062] Temperature Time Hot Cover (35℃) On 30℃ 25min 4℃ Hold

[0063] 5) When the PCR instrument temperature reaches 4°C, immediately add 20 μL of DNB stop buffer and mix thoroughly by slowly pipetting up and down 5-8 times with a wide-bore pipette tip.

[0064] 6) Measure DNB concentration using Qubit.

[0065] 3.3 DNB pooling and loading

[0066] 1) Take 100 μL of DNB and add 32 μL of DLBⅡ, then mix using a flared pipette tip.

[0067] 2)DNB loading

[0068] Use MGIDL-200H to load DNB onto the slide. After the slide loading is completed, remove the slide and prepare it for sequencing.

[0069] 3.4 Sequencing

[0070] Prepare two sets of reagents from the same batch, add the hot mix and cold mix stored in LTE and the hot mix and cold mix stored in DMSO, respectively, and use the same script for SE50 sequencing.

[0071] Experimental conditions:

[0072] Table 13-1 Hot mix reagent tank preparation components

[0073] Hot mix conc.0.6μM Enzyme DNA polymerase Enzyme conc.10μg / mL

[0074] Table 13-2 Cold mix reagent tank preparation components

[0075] Cold mix conc.4μM Enzyme DNA polymerase Enzyme conc.10μg / mL

[0076] Script conditions:

[0077] Table 14 Script conditions

[0078] Step Tm (℃) Time (s) Hot polymerization 6530 Cold polymerization 6560 Cleavage 5045

[0079] 4. Experimental results and analysis

[0080] The results are shown in Table 15 and Figure 1. 1) After 11 days of storage in LTE buffer at room temperature, the Runon (%) of the dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II increased by 118%. After 22 days of storage, the Runon was so high that the calculation was inaccurate (the Runon curve reached a plateau at 20 cycles). 2) After 11 days of storage in DMSO at room temperature, the Runon (%) of the dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II increased by only 23%. After 22 days of storage, the Runon increased by only 17% (the lower Runon than that after 11 days may be due to experimental error). Moreover, after 22 days of storage in DMSO at room temperature, the Q30% of SE50 remained consistent with that of freshly prepared reagents (94.83% vs 94.01%), the MappingRate decreased by 0.23%, and the AvgErrorRate increased by only 2%, fully demonstrating that the HotMPS dNTPs Mix and HotMPS The dNTPs in dNTPs Mix II are stable in anhydrous DMSO.

[0081] Table 15 Sequencing data comparison

[0082]

[0083] 5. Experimental Conclusion

[0084] After 22 days of storage at room temperature in LTE, the dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II showed a decrease in Q30% from 94.65% to 68.87%. The Runon% was so high that it could not be accurately calculated (reaching a plateau after 20 cycles). The data could hardly be aligned to the reference genome (Mapping Rate was only 9%), and the error rate of the data in this 9% alignment was as high as 3.7%.

[0085] The dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II were stored in DMSO. After 22 days of storage at room temperature, Q30% did not decrease, Runon% increased by 17%, MappingRate decreased by 0.23%, and AvgErrorRate increased by 2%.

[0086] Therefore, the dNTPs in HotMPS dNTPs Mix and HotMPS dNTPs Mix II can be stored for a long time in anhydrous DMSO, which is consistent with theoretical reasoning. The conclusion of this experiment is in line with expectations.

[0087] Example 2

[0088] The materials and consumables used (except the tested organic solvent) and the experimental steps were the same as those in Example 1. Only the results of 0 days and 11 days at room temperature were compared here. Since it was expected to be more stable than in LTE, sequencing was performed for comparison.

[0089] Table 16 Comparison of other organic compounds and DMSO

[0090]

[0091] Note: The purity of the dNTPs used in the above tests is higher than that in the first table; therefore, the Runon% on day 0 is lower than that in the first table;

[0092] dNTPs were stored in DMAC (dimethylacetamide) and DMF (N,N-dimethylformamide) at room temperature, and the Runon% at 0 and 11 days were consistent;

[0093] dNTPs were stored in NMP (N-methylpyrrolidone) at room temperature for 11 days. Although the Runon% increased by 31%, the Q30% of SE100 was still 88.84%, which was still more stable than in LTE.

[0094] dNTPs were stored in NMF (N-methylformamide). Although the Runon% increased by 140%, the Q30% was still 86.71%, which was more stable than in LTE.

[0095] In the description of this specification, the reference terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" mean that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art can combine and combine different embodiments or examples described in this specification and features of different embodiments or examples without contradiction.

[0096] Although the embodiments of the present invention have been shown and described above, it will be understood that the above embodiments are illustrative and are not to be construed as limitations on the present invention. A person skilled in the art may change, modify, replace and modify the above embodiments within the scope of the present invention.

Claims

1. A dNTP storage reagent, characterized in that The reagents include one or more of dimethyl sulfoxide, sulfolane, tetrahydrofuran, dimethylformamide, dimethylacetamide, N,N-dimethylformamide, N-methylformamide and N-methylpyrrolidone.

2. The dNTP storage reagent according to claim 1, wherein The reagent is used to improve the storage stability of dNTP.

3. The dNTP storage reagent according to claim 1 or 2, characterized in that The dNTP is modified with a reversible blocking group.

4. The dNTP storage reagent according to claim 3, characterized in that The reversible blocking group is selected from at least one of the following: an ester bond, an amide, an imide, an ether bond, an anhydride, an acid chloride, a carbonate, and a carbamate.

5. The use of the reagent in preserving dNTPs, characterized in that, The reagent is selected from the dNTP preservation reagent according to any one of claims 1 to 4.

6. A method for preserving dNTPs, characterized in that, include: The dNTP storage reagent according to any one of claims 1 to 4 is mixed with dNTPs.

7. The method according to claim 6, characterized in that Based on the total volume of the dNTP and the dNTP storage reagent, the reagent content is 50-99.9%.